Earnings Preview: Anavex Life Sciences Forecasts EPS Drop

Analysts anticipate Anavex Life Sciences Corp. to report a notable earnings decrease for the quarter ending September 30, 2024. The report presents a concerning outlook with a decrease in earnings per share, potentially affecting investor sentiment.

Date: 25-12-2024

AI Rating: 4

Anavex Life Sciences Corp. is projected to report an earnings per share (EPS) of $-0.17 for the quarter ending September 30, 2024. This forecast represents a significant 41.67% decrease compared to the same quarter last year. Such a substantial decline in EPS is likely to alarm investors, indicating possible deterioration in the company's financial performance.

Over the past year, Anavex has met analyst expectations once and exceeded expectations in three other quarters. However, the current forecast may lead to skepticism regarding the company's ability to maintain this trend, especially with such a notable drop in EPS. The ongoing negative EPS also contributes to a concerning price to earnings (P/E) ratio of -15.40, starkly contrasting with the industry average of -1.30, indicating that the stock is currently being priced at a much higher relative loss than its peers.

The "days to cover" for Anavex exceeds 12 days, suggesting that investors may be holding onto their positions longer than usual, possibly waiting for a turnaround. This high short interest could lead to volatility in the stock price, especially if the earnings report deviates from expectations.

Stocks: AVXL